Moreover, CS1 and CS2, two potent small molecule inhibitors of FTO, exert effective anti-tumor effects by suppressing immune checkpoint gene expression, especially LILRB4, in an m6A-dependent manner, thus sensitizing cancer cells to T cell cytotoxicity in leukemia and PC models [188]. This evidence concerns the gene FTO and cancer.